Dr. Petersen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 E Idaho St
Boise, ID 83712Phone+1 208-381-2711Fax+1 208-381-2707
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1983 - 1985
- University of Copenhagen Medical SchoolClass of 1978
Certifications & Licensure
- ID State Medical License 2018 - 2025
- UT State Medical License 1992 - 2024
Clinical Trials
- Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer Start of enrollment: 2004 Apr 01
- Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant Start of enrollment: 2003 May 01
- Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders Start of enrollment: 2006 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 177 citationsNonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid LeukemiaBoglarka Gyurkocza, Rainer Storb, Barry E. Storer, Thomas R. Chauncey, Thoralf Lange
Journal of Clinical Oncology. 2010-06-10 - 438 citationsPhase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation ...Richard A. Nash, Joseph H. Antin, Chatchada Karanes, Joseph W. Fay, Belinda R. Avalos
Blood. 2000-09-15 - 55 citationsRadionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity.Scott I. Bearman, Finn Bo Petersen, Schor Ra, Denney Jd, LD Fisher
Bone Marrow Transplantation. 1990-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: